Cannara Biotech (LOVE.TO) reported fiscal Q3 earnings of C$0.05 per diluted share from C$0.04 a share in the same period a year earlier.
Total revenue rose to C$31.8 million in the three months through May 31, compared with C$27.3 million a year ago, the cannabis company said Wednesday.
Analysts polled by FactSet expected sales of C$31.2 million.